First Trust NYSE Arca Biotechnology Index Fund (NYSEARCA:FBT) Shares Gap Down – Here’s What Happened

First Trust NYSE Arca Biotechnology Index Fund (NYSEARCA:FBT) gapped down prior to trading on Monday . The stock had previously closed at $273.91, but opened at $265.60. First Trust NYSE Arca Biotechnology Index Fund shares last traded at $264.8590, with a volume of 2,258 shares trading hands.

First Trust NYSE Arca Biotechnology Index Fund Stock Up 0.3%

The company has a market capitalization of $2.96 billion, a P/E ratio of 21.72 and a beta of 0.66. The company’s 50-day simple moving average is $254.55 and its 200 day simple moving average is $224.77.

Institutional Investors Weigh In On First Trust NYSE Arca Biotechnology Index Fund

Large investors have recently bought and sold shares of the business. Russell Investments Group Ltd. lifted its position in shares of First Trust NYSE Arca Biotechnology Index Fund by 7,900.0% in the third quarter. Russell Investments Group Ltd. now owns 160 shares of the company’s stock worth $29,000 after buying an additional 158 shares during the last quarter. AG Campbell Advisory LLC acquired a new position in shares of First Trust NYSE Arca Biotechnology Index Fund during the 4th quarter valued at about $31,000. Cassaday & Co Wealth Management LLC acquired a new position in shares of First Trust NYSE Arca Biotechnology Index Fund during the 1st quarter valued at about $34,000. Continuum Advisory LLC acquired a new position in shares of First Trust NYSE Arca Biotechnology Index Fund during the 2nd quarter valued at about $35,000. Finally, Parallel Advisors LLC raised its stake in shares of First Trust NYSE Arca Biotechnology Index Fund by 1,300.0% in the 1st quarter. Parallel Advisors LLC now owns 182 shares of the company’s stock valued at $37,000 after acquiring an additional 169 shares in the last quarter.

About First Trust NYSE Arca Biotechnology Index Fund

The First Trust NYSE Arca Biotechnology Index Fund (FBT) is an exchange-traded fund that is based on the NYSE Arca Biotechnology index. The fund tracks an equal-weighted index of US biotechnology stocks. FBT was launched on Jun 19, 2006 and is managed by First Trust.